US Markets Diverge: Nasdaq Slumps as Tech Giants and SpaceX Weigh Down

Wall Street experienced a split session on Monday, as the Nasdaq and S&P 500 retreated under the weight of megacap technology stocks and a tumbling SpaceX. While tech sentiment faltered, the Dow Jones Industrial Average managed to post gains, supported by strength in the healthcare and industrial sectors.

Tech Retreat: Alphabet and SpaceX Lead the Decline

The Nasdaq Composite bore the brunt of the selling pressure, sliding 339.67 points, or 1.28%, to settle at 26,178.26. This downturn was largely driven by sharp declines in "megacap" tech heavyweights, including Alphabet, Meta, Amazon, and Microsoft. Investors are increasingly scrutinizing the massive capital expenditure being poured into artificial intelligence infrastructure by hyperscalers.

A significant drag on the Nasdaq was SpaceX, which saw its shares tumble following its first-ever debt offering. Despite the stock dip, the Elon Musk-led company reported a robust liquidity position, stating it held approximately $100.8 billion in cash and cash equivalents as of June 19. Analysts noted that while the tech sector is currently sentiment-driven, the fundamental demand for AI data center components remains a strong long-term driver.

Geopolitical Shifts and Energy Markets

In a move that provided some relief to global markets, oil prices fell after U.S. and Iranian officials reported "great progress" during talks in Switzerland. Mediators indicated that Washington and Tehran have agreed on a 60-day roadmap toward a final deal. While tensions remain high regarding Lebanon and the Strait of Hormuz, the potential for stabilized energy prices is viewed as a positive catalyst for both consumers and businesses.

The Fed Factor: Inflation Data and Yields

The market sentiment was further complicated by a shift in Federal Reserve expectations. With the market anticipating a more hawkish stance under new Chair Kevin Warsh, there is a growing focus on returning to price stability. This outlook has pushed U.S. Treasury yields higher, putting downward pressure on stock prices.

All eyes are now on Thursday’s Personal Consumption Expenditures (PCE) data, the Federal Reserve's preferred inflation gauge. A reading that exceeds expectations could reinforce the hawkish narrative. Currently, according to LSEG data, markets are pricing in a 25-basis-point rate hike from the Fed in September.

Notable Corporate Movers

Beyond the tech giants, the biotech sector saw significant action. Apogee Therapeutics witnessed a surge in its share price after AbbVie announced its intention to acquire the company in an all-cash deal valued at $10.9 billion. Meanwhile, investors are looking ahead to Wednesday's quarterly results from Micron Technology, a key bellwether for the semiconductor industry, which has seen its shares rise nearly 300% this year.

Key Takeaways

  • Tech Volatility: The Nasdaq fell 1.28% as investors questioned the high infrastructure spending of AI hyperscalers and reacted to SpaceX's debt offering.
  • Geopolitical Progress: Potential breakthroughs in U.S.-Iran negotiations have led to a decline in oil prices, offering a potential economic catalyst.
  • Macro Watch: Market participants are bracing for the upcoming PCE inflation data to gauge the Federal Reserve's next moves regarding interest rate hikes.